Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sso1 Inhibitors

Sso1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Sso1, a member of the SNARE (Soluble NSF Attachment Protein Receptor) family, which is crucial for membrane fusion events in eukaryotic cells. Sso1, primarily found in yeast, functions as a t-SNARE (target SNARE) protein, playing a key role in exocytosis, the process by which cells secrete molecules or transport materials to the cell surface. It operates by forming a complex with v-SNARE (vesicle SNARE) proteins located on vesicles, facilitating the docking and fusion of these vesicles with the plasma membrane. This fusion event is essential for various cellular processes, including protein secretion, membrane repair, and the regulated release of cellular components. Inhibitors of Sso1 interfere with its ability to participate in SNARE complex formation, thereby disrupting membrane fusion and vesicle transport.

The mechanism of action of Sso1 inhibitors typically involves binding to the SNARE domain of the protein, either preventing its interaction with other SNARE proteins or altering its conformation in such a way that it cannot engage in the fusion machinery. Some inhibitors may compete directly with the natural SNARE binding partners, while others may destabilize the protein's structure, rendering it non-functional. By inhibiting Sso1, these compounds disrupt the vesicle docking and fusion processes, which can affect key cellular functions such as secretion, membrane recycling, and intracellular trafficking. Research into Sso1 inhibitors provides valuable insights into the fundamental mechanisms of membrane fusion and how SNARE proteins coordinate the precise control of vesicle transport and exocytosis. This understanding expands the broader knowledge of how cells manage communication, nutrient exchange, and the dynamic regulation of their membrane systems, offering insights into the intricate cellular transport networks.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

N-Ethylmaleimide

128-53-0sc-202719A
sc-202719
sc-202719B
sc-202719C
sc-202719D
1 g
5 g
25 g
100 g
250 g
$22.00
$68.00
$210.00
$780.00
$1880.00
19
(1)

A compound that can modify cysteine residues and potentially interfere with SNARE complex formation, indirectly affecting Sso1 function.

Pitstop 2

1419320-73-2sc-507418
10 mg
$360.00
(0)

Pitstop 2 inhibits clathrin-mediated endocytosis, potentially influencing vesicle dynamics related to Sso1.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

A small molecule that inhibits dynamin, impacting vesicular budding and potentially affecting Sso1-related processes.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Disrupts the structure and function of the Golgi apparatus, potentially influencing vesicular transport involving Sso1.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

A polyether antibiotic that disrupts Golgi function, which could indirectly affect Sso1-mediated vesicle fusion.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Inhibits N-linked glycosylation, impacting protein trafficking and potentially Sso1 function.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$187.00
$670.00
11
(1)

A specific inhibitor of the Golgi BFA resistance factor 1 (GBF1), it may affect vesicular transport processes involving Sso1.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$180.00
$299.00
59
(1)

A compound that stabilizes actin filaments, potentially influencing cytoskeletal dynamics related to Sso1-mediated transport.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A phosphoinositide 3-kinase inhibitor, which could affect vesicle formation and transport, indirectly impacting Sso1 function.